Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Spotify Technology SA ha un obiettivo di prezzo di consenso pari a $719.17, stabilito in base alle ultime valutazioni degli analisti di 30. Le ultime 3 valutazioni degli analisti sono state rilasciate da Citigroup, Guggenheim y Oppenheimer il septiembre 9, 2025, septiembre 3, 2025 y agosto 18, 2025. Con un obiettivo di prezzo medio di $808.33 tra le Citigroup, Guggenheim y Oppenheimer, c'è un implicito 13.85% upside per Spotify Technology SA da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
09/09/2025 | 5.64% | Citigroup | $715 → $750 | Maintains | Neutral | |||
09/03/2025 | 19.72% | Guggenheim | $850 → $850 | Reiterates | Buy → Buy | |||
08/18/2025 | 16.2% | Oppenheimer | $750 → $825 | Maintains | Outperform | |||
08/18/2025 | 19.72% | Guggenheim | $800 → $850 | Maintains | Buy | |||
07/30/2025 | 12.68% | Guggenheim | $840 → $800 | Maintains | Buy | |||
07/30/2025 | 5.64% | Barclays | $800 → $750 | Maintains | Overweight | |||
07/30/2025 | 12.68% | Morgan Stanley | $850 → $800 | Maintains | Overweight | |||
07/30/2025 | 19.72% | UBS | $895 → $850 | Maintains | Buy | |||
07/30/2025 | 12.68% | Benchmark | $840 → $800 | Maintains | Buy | |||
07/30/2025 | 16.9% | Keybanc | $860 → $830 | Maintains | Overweight | |||
07/30/2025 | -4.36% | Rosenblatt | $703 → $679 | Maintains | Neutral | |||
07/29/2025 | 5.64% | Wells Fargo | $740 → $750 | Maintains | Overweight | |||
07/24/2025 | 12.68% | Oppenheimer | → $800 | Upgrade | Perform → Outperform | |||
07/23/2025 | 9.16% | Deutsche Bank | $700 → $775 | Maintains | Buy | |||
07/11/2025 | 9.86% | JP Morgan | $730 → $780 | Maintains | Overweight | |||
07/11/2025 | 21.13% | Keybanc | $640 → $860 | Maintains | Overweight | |||
07/10/2025 | 19.72% | Morgan Stanley | $700 → $850 | Maintains | Overweight | |||
07/10/2025 | 18.31% | Benchmark | $700 → $840 | Maintains | Buy | |||
07/09/2025 | 12.68% | Barclays | $650 → $800 | Maintains | Overweight | |||
07/08/2025 | 18.31% | Bernstein | $825 → $840 | Maintains | Outperform | |||
07/02/2025 | 9.16% | Goldman Sachs | $680 → $775 | Maintains | Buy | |||
07/02/2025 | 19.72% | Canaccord Genuity | $775 → $850 | Maintains | Buy | |||
06/27/2025 | 26.06% | UBS | $680 → $895 | Maintains | Buy | |||
06/26/2025 | 26.76% | B of A Securities | $700 → $900 | Maintains | Buy | |||
06/25/2025 | 18.31% | Guggenheim | $725 → $840 | Maintains | Buy | |||
06/18/2025 | -9.86% | Cantor Fitzgerald | $610 → $640 | Maintains | Neutral | |||
06/17/2025 | 26.76% | Pivotal Research | $800 → $900 | Maintains | Buy | |||
06/16/2025 | 5.64% | Evercore ISI Group | $650 → $750 | Maintains | Outperform | |||
06/04/2025 | 2.82% | JP Morgan | $670 → $730 | Maintains | Overweight | |||
05/20/2025 | 9.16% | Canaccord Genuity | $700 → $775 | Maintains | Buy | |||
05/12/2025 | 2.11% | Guggenheim | $675 → $725 | Maintains | Buy | |||
05/02/2025 | -22.53% | Loop Capital | $435 → $550 | Maintains | Hold | |||
05/01/2025 | 2.82% | Baird | $700 → $730 | Maintains | Outperform | |||
04/30/2025 | 12.68% | Pivotal Research | $725 → $800 | Maintains | Buy | |||
04/30/2025 | -14.08% | Cantor Fitzgerald | $520 → $610 | Maintains | Neutral | |||
04/30/2025 | -8.45% | Barclays | $710 → $650 | Maintains | Overweight | |||
04/30/2025 | -6.34% | Macquarie | $665 → $665 | Maintains | Outperform | |||
04/30/2025 | -5.63% | JP Morgan | $640 → $670 | Maintains | Overweight | |||
04/30/2025 | -8.45% | Evercore ISI Group | $700 → $650 | Maintains | Outperform | |||
04/30/2025 | -7.46% | Rosenblatt | $658 → $657 | Maintains | Neutral | |||
04/25/2025 | -6.34% | Macquarie | $600 → $665 | Maintains | Outperform | |||
04/21/2025 | -7.04% | Wolfe Research | → $660 | Upgrade | Peer Perform → Outperform | |||
04/16/2025 | -26.76% | Cantor Fitzgerald | $600 → $520 | Maintains | Neutral | |||
04/15/2025 | -4.22% | UBS | $690 → $680 | Maintains | Buy | |||
04/09/2025 | -11.97% | Keybanc | $675 → $625 | Maintains | Overweight | |||
04/08/2025 | -9.86% | JP Morgan | $730 → $640 | Maintains | Overweight | |||
04/02/2025 | -2.82% | UBS | $720 → $690 | Maintains | Buy | |||
03/28/2025 | 4.23% | Wells Fargo | $690 → $740 | Maintains | Overweight | |||
03/26/2025 | 4.23% | China Renaissance | → $740 | Initiates | → Buy | |||
02/24/2025 | -4.93% | Guggenheim | $675 → $675 | Reiterates | Buy → Buy | |||
02/14/2025 | 1.41% | Citigroup | $540 → $720 | Maintains | Neutral | |||
02/06/2025 | -2.11% | Goldman Sachs | $550 → $695 | Maintains | Buy | |||
02/05/2025 | 1.41% | Benchmark | $600 → $720 | Maintains | Buy | |||
02/05/2025 | 2.82% | JP Morgan | $555 → $730 | Maintains | Overweight | |||
02/05/2025 | -4.93% | Keybanc | $600 → $675 | Maintains | Overweight | |||
02/05/2025 | -2.82% | Wells Fargo | $520 → $690 | Maintains | Overweight | |||
02/05/2025 | — | Barclays | $475 → $710 | Maintains | Overweight | |||
02/05/2025 | -5.63% | Morgan Stanley | $550 → $670 | Maintains | Overweight | |||
02/05/2025 | -7.32% | Rosenblatt | $473 → $658 | Downgrade | Buy → Neutral | |||
02/05/2025 | -4.93% | Guggenheim | $520 → $675 | Maintains | Buy | |||
02/05/2025 | -1.41% | Canaccord Genuity | $650 → $700 | Maintains | Buy | |||
01/31/2025 | -8.45% | Canaccord Genuity | $560 → $650 | Maintains | Buy | |||
01/31/2025 | -15.49% | Keybanc | $555 → $600 | Maintains | Overweight | |||
01/30/2025 | -15.49% | Macquarie | $500 → $600 | Maintains | Outperform | |||
01/28/2025 | -32.39% | Cantor Fitzgerald | $490 → $480 | Reiterates | Neutral → Neutral | |||
01/17/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
01/16/2025 | -26.76% | Benchmark | $520 → $520 | Reiterates | Buy → Buy | |||
01/15/2025 | -23.94% | UBS | $485 → $540 | Maintains | Buy | |||
01/10/2025 | -21.83% | Keybanc | $520 → $555 | Maintains | Overweight | |||
01/08/2025 | -22.53% | Goldman Sachs | $490 → $550 | Maintains | Buy | |||
12/02/2024 | -21.13% | Canaccord Genuity | $525 → $560 | Maintains | Buy | |||
11/14/2024 | -30.98% | Goldman Sachs | $430 → $490 | Maintains | Buy | |||
11/14/2024 | -26.06% | Canaccord Genuity | $475 → $525 | Maintains | Buy | |||
11/13/2024 | -29.58% | Macquarie | $395 → $500 | Maintains | Outperform | |||
11/13/2024 | -41.41% | TD Cowen | $356 → $416 | Maintains | Hold | |||
11/13/2024 | -27.46% | B of A Securities | $430 → $515 | Maintains | Buy | |||
11/13/2024 | -26.76% | Benchmark | $440 → $520 | Maintains | Buy | |||
11/13/2024 | -26.76% | Wells Fargo | $470 → $520 | Maintains | Overweight | |||
11/13/2024 | -36.62% | Piper Sandler | $330 → $450 | Maintains | Neutral | |||
11/13/2024 | -33.1% | Barclays | $385 → $475 | Maintains | Overweight | |||
11/13/2024 | -26.76% | Keybanc | $490 → $520 | Maintains | Overweight | |||
11/13/2024 | -25.35% | JP Morgan | $425 → $530 | Maintains | Overweight | |||
11/13/2024 | -35.21% | Morgan Stanley | $430 → $460 | Maintains | Overweight | |||
11/13/2024 | -31.69% | Phillip Securities | $420 → $485 | Downgrade | Buy → Accumulate | |||
11/11/2024 | -38.03% | Benchmark | $430 → $440 | Maintains | Buy | |||
11/06/2024 | -38.03% | Deutsche Bank | $430 → $440 | Maintains | Buy | |||
10/28/2024 | -33.8% | Wells Fargo | $420 → $470 | Maintains | Overweight | |||
10/23/2024 | -39.44% | Morgan Stanley | $400 → $430 | Maintains | Overweight | |||
10/17/2024 | -38.31% | Rosenblatt | $399 → $438 | Maintains | Buy | |||
10/16/2024 | -30.98% | Keybanc | $440 → $490 | Maintains | Overweight | |||
09/30/2024 | -52.11% | Cantor Fitzgerald | $340 → $340 | Reiterates | Neutral → Neutral | |||
09/23/2024 | -52.11% | Cantor Fitzgerald | $340 → $340 | Reiterates | Neutral → Neutral | |||
09/19/2024 | -28.17% | Pivotal Research | $460 → $510 | Maintains | Buy | |||
09/16/2024 | -38.03% | Keybanc | $420 → $440 | Maintains | Overweight | |||
09/05/2024 | -52.11% | Cantor Fitzgerald | → $340 | Initiates | → Neutral | |||
08/29/2024 | -35.21% | Evercore ISI Group | $420 → $460 | Maintains | Outperform | |||
07/24/2024 | -40.84% | Guggenheim | $400 → $420 | Maintains | Buy | |||
07/24/2024 | -49.3% | Barclays | $350 → $360 | Maintains | Overweight | |||
07/24/2024 | -43.66% | Morgan Stanley | $370 → $400 | Maintains | Overweight | |||
07/24/2024 | -39.44% | Benchmark | $405 → $430 | Maintains | Buy |
El último precio objetivo de Spotify Technology (NYSE:SPOT) fue comunicado por Citigroup el septiembre 9, 2025. La firma de analistas fijó un precio objetivo para $750.00 que espera SPOT a rise dentro de 12 meses (un posible 5.64% upside). 93 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Spotify Technology (NYSE:SPOT) fue proporcionada por Citigroup, y Spotify Technology mantuvo su neutral calificación.
La última revisión al alza de Spotify Technology SA se produjo en julio 24, 2025, cuando Oppenheimer elevó su precio objetivo a $800. Oppenheimer anteriormente tenía a perform para Spotify Technology SA.
La última revisión a la baja de Spotify Technology SA se produjo en febrero 5, 2025, cuando Rosenblatt cambió su precio objetivo de $473 a $658 para Spotify Technology SA.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Spotify Technology, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Spotify Technology se registró el septiembre 9, 2025, por lo que la próxima calificación estará disponible en torno al septiembre 9, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Spotify Technology (SPOT) fue un mantuvo con un precio objetivo de $715.00 a $750.00. El precio actual al que cotiza Spotify Technology (SPOT) es de $709.99, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.